Morgan Stanley’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-197,565
Closed -$45K – 8139
2022
Q2
$45K Buy
197,565
+141,264
+251% +$53.4K ﹤0.01% 6667
2022
Q1
$33K Sell
56,301
-310,407
-85% -$222K ﹤0.01% 6913
2021
Q4
$377K Sell
366,708
-494,023
-57% -$652K ﹤0.01% 5712
2021
Q3
$1.2M Buy
860,731
+255,514
+42% +$465K ﹤0.01% 4936
2021
Q2
$1.35M Buy
605,217
+112,733
+23% +$263K ﹤0.01% 4912
2021
Q1
$1.41M Sell
492,484
-598,340
-55% -$1.83M ﹤0.01% 4513
2020
Q4
$2.87M Buy
1,090,824
+342,662
+46% +$931K ﹤0.01% 3834
2020
Q3
$1.29M Buy
748,162
+25,176
+3% +$49K ﹤0.01% 4023
2020
Q2
$1.11M Buy
722,986
+43,344
+6% +$64.7K ﹤0.01% 4092
2020
Q1
$944K Buy
679,642
+30,401
+5% +$54.6K ﹤0.01% 4001
2019
Q4
$1.18M Buy
649,241
+74,634
+13% +$177K ﹤0.01% 4425
2019
Q3
$1.58M Sell
574,607
-9,548
-2% -$33.7K ﹤0.01% 3984
2019
Q2
$2.72M Buy
584,155
+362,903
+164% +$1.86M ﹤0.01% 3519
2019
Q1
$1.16M Sell
221,252
-1,053,199
-83% -$6.35M ﹤0.01% 4000
2018
Q4
$6.63M Buy
1,274,451
+1,257,331
+7,344% +$6.59M ﹤0.01% 2556
2018
Q3
$92K Buy
17,120
+15,870
+1,270% +$36K ﹤0.01% 5719
2018
Q2
$2K Sell
1,250
-18,500
-94% -$34.8K ﹤0.01% 6569
2018
Q1
$48K Hold
19,750
– – ﹤0.01% 5895
2017
Q4
$43K Buy
19,750
+17,300
+706% +$40.8K ﹤0.01% 5868
2017
Q3
$8K Sell
2,450
-64,180
-96% -$272K ﹤0.01% 6217
2017
Q2
$342K Buy
66,630
+49,438
+288% +$244K ﹤0.01% 5029
2017
Q1
$71K Buy
+17,192
New +$69.8K ﹤0.01% 5724

Other funds holding NBEV

Morgan Stanley's NBEV Position: Q3 2022 in Review

Morgan Stanley sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 197,565 shares — an estimated $45K sold.

Morgan Stanley first reported a position in NBEV in Q1 2017 and held it in 22 quarters. The position peaked at $6.63M in Q4 2018. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Morgan Stanley reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 197,565 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022, an estimated $45K.
  • Morgan Stanley first reported a position in NewAge, Inc. Common Stock (Delaware) in Q1 2017 and held it in 22 quarters.
  • Morgan Stanley's NewAge, Inc. Common Stock (Delaware) position peaked at $6.63M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.